Another widely used enzyme-based therapy is tissue plasminogen activator (tPA), which is administered for the dissolution of blood clots in ischemic stroke and myocardial infarction patients, significantly improving patient outcomes by restoring blood flow [33]. This evidence concerns the gene PLAT and myocardial infarction.